Clinical Trial: Establishment and early identification of risk factors for recurrence of haemorrhagic stroke with traditional Chinese and Western medicine. (China)

Posted On: 2026-09-08

China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Establishment and early identification of risk factors for recurrence of haemorrhagic stroke with traditional Chinese and Western medicine.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131820

Registration Time: 2026/09/07

Type: Observational study

Primary Sponsor: The First People's Hospital of Lianyungang City

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=271463

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Establishment and early identification of risk factors for recurrence of haemorrhagic stroke with traditional Chinese and Western medicine. (China)